Ravi Gupta and colleagues argue that we need to reconsider standards for targeted pharmaceutical marketing to doctors through speaker programmes, consulting programmes, and advisory board positions.

Gupta R, Ramachandran R, Ross JS. Tackling the excesses of pharmaceutical marketing and promotion. BMJ. 2024 May 21;385:e076797. doi: 10.1136/bmj-2023-076797. PMID: 38772671.